148 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Kelsen
    Kelsen
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Panageas
    Panageas
  9. Hensley
    Hensley
  10. Moore
    Moore

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  8. Biostatistics Service (26)
  9. Epidemiology and Biostatistics (26)
  10. Nursing (19)
  1. "recombinant granulocyte colony stimulating factor"
Formats
  1. Journal Article (143)
  2. Conference Paper (5)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Clifford Hudis (19)
  2. Larry Norton (19)
  3. Andrew Seidman (14)
  4. Andrew Zelenetz (12)
  5. Craig Moskowitz (10)
  6. David Kelsen (10)

More People

Years
  1. 2024 (1)
  2. 2015 (2)
  3. 2014 (3)
  4. 2013 (4)
  5. 2012 (5)
  6. 2011 (10)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer (14)
  3. Clinical Breast Cancer (6)
  4. Seminars in Oncology (6)
  5. Blood (5)
  6. Gynecologic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (27)
  3. Wiley Blackwell (16)
  4. Springer (11)
  5. Oxford University Press (9)
  6. Nature Publishing Group (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity
    Journal Article

    Lin, H.; de Stanchina, E.; Zhou, X. K.; Hong, F.; Seidman, A.; Fornier, M.; Xiao, W. L.; Kennelly, E. J.; Wesa, K.; Cassileth, B. R.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Reply to comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia
    Journal Article

    Heaney, M. L.; Toy, E. L.; Vekeman, F.
    Cancer (2010)

    Fulltext@MSK | Save
  • Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: Two clinical trials
    Journal Article

    Fornier, M.
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea
    Journal Article

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Morris, P.; Abbruzzi, A.; Chen, C.; Steingart, R.; Patil, S.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: Evidence of symptom palliation from chemotherapy
    Journal Article

    Cianfrocca, M.; Lee, S.; Von Roenn, J.; Tulpule, A.; Dezube, B. J.; Aboulafia, D. M.; Ambinder, R. F.; Lee, J. Y.; Krown, S. E.; Sparano, J. A.
    Cancer (2010)

    Fulltext@MSK | Save
  • Phase i trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer
    Journal Article

    Tew, W. P.; Radovich, D.; O'reilly, E.; Schwartz, G.; Schrag, D.; Saltz, L. B.; Kelsen, D. P.; Kepler, S.; Ilson, D. H.
    Investigational New Drugs (2009)

    Fulltext@MSK | Save
  • A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma
    Journal Article

    Sugarman, S.; Wasserheit, C.; Hodgman, E.; Coglianese, M.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2009)

    Fulltext@MSK | Save
  • The Case for Chemotherapy only for Localized Hodgkin Lymphoma
    Journal Article

    Straus, D. J.
    The Oncologist (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors
    Journal Article

    Ku, G. Y.; O'Reilly, E. M.; Saltz, L. B.; Schrag, D.; Maki, R. G.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2009)

    Fulltext@MSK | Save